News

Is Vertex Pharmaceuticals Stock a Buy?
Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex ...
Vertex Pharmaceuticals price target raised to $462 from $459 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $462 from $459 and keeps an Equal Weight rating on the ...
Morgan Stanley Remains a Hold on Vertex Pharmaceuticals (VRTX)
Morgan Stanley analyst Terence Flynn maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...